Home / R3HDM2 Knockout Cell Lines

R3HDM2 Knockout Cell Lines

Gene: R3HDM2

Official Full Name: R3H domain containing 2provided by HGNC

Gene Summary: Enables RNA binding activity. Predicted to be located in nucleus. [provided by Alliance of Genome Resources, Apr 2025]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO30208 R3HDM2 Knockout cell line (HeLa) Human R3HDM2 1:3~1:6 Negative Online Inquiry
KO30209 R3HDM2 Knockout cell line (HCT 116) Human R3HDM2 1:2~1:4 Negative Online Inquiry
KO30210 R3HDM2 Knockout cell line (HEK293) Human R3HDM2 1:3~1:6 Negative Online Inquiry
KO30211 R3HDM2 Knockout cell line (A549) Human R3HDM2 1:3~1:4 Negative Online Inquiry

Background

R3HDM2 Gene Knockout Cell Lines are engineered cellular models designed for the specific disruption of the R3HDM2 gene, crucial for understanding its role in various biological processes and disease states. These cell lines are generated through advanced CRISPR-Cas9 technology, which allows for precise editing of the genome, resulting in the complete knockout of the targeted gene. This mechanism facilitates a comprehensive investigation into the phenotypic changes and molecular pathways influenced by the absence of R3HDM2, creating a valuable tool for both basic and applied research.

The key functions of R3HDM2 gene knockout models lie in their ability to help elucidate the gene’s contributions to cellular functions such as gene expression regulation, apoptosis, and antiviral responses. By studying these cell lines, researchers can gain insights not only into fundamental biological processes but also into the molecular underpinnings of diseases such as cancer and viral infections, where R3HDM2 activity may be implicated.

In the clinical research setting, R3HDM2 knockout cell lines provide an essential platform for drug screening and developmental studies focused on therapeutic interventions. They enable the assessment of drug efficacy and the identification of potential biomarkers associated with the activity of therapeutic agents. This model surpasses traditional methods by offering more reliable in vitro data through reproducible and controllable conditions.

One of the unique selling points of our R3HDM2 Gene Knockout Cell Lines is their validated performance in various assays, making them a dependable choice for researchers looking to generate high-quality data. Unlike alternative models, these cell lines come with comprehensive support and detailed documentation, ensuring ease of integration into existing workflows.

For researchers and clinicians, the R3HDM2 knockout models represent not just a resource but an opportunity to advance scientific knowledge and therapeutic development. Our company, with a strong commitment to innovation and quality in biological products, delivers reliable and effective solutions that empower scientists to push the boundaries of discovery, making significant contributions to the field of biomedical research.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.